Logos Global Management Lp Top Holdings and 13F Report (2025) About Logos Global Management LpInvestment ActivityLogos Global Management Lp has $562.54 million in total holdings as of March 31, 2025.Logos Global Management Lp owns shares of 39 different stocks, but just 17 companies or ETFs make up 80% of its holdings.Approximately 42.62% of the portfolio was purchased this quarter.About 70.30% of the portfolio was sold this quarter.This quarter, Logos Global Management Lp has purchased 47 new stocks and bought additional shares in 10 stocks.Logos Global Management Lp sold shares of 6 stocks and completely divested from 19 stocks this quarter.Largest Holdings IDEAYA Biosciences $57,330,000Revolution Medicines $56,576,000Akero Therapeutics $48,576,000Janux Therapeutics $44,550,000Nuvalent $35,460,000 Largest New Holdings this Quarter 670703107 - Nuvalent $35,460,000 Holding881624209 - Teva Pharmaceutical Industries $26,129,000 Holding98420N105 - Xenon Pharmaceuticals $21,807,500 Holding492327101 - Keros Therapeutics $20,380,000 Holding282559103 - 89bio $18,175,000 Holding Largest Purchases this Quarter Nuvalent 500,000 shares (about $35.46M)Teva Pharmaceutical Industries 1,700,000 shares (about $26.13M)Xenon Pharmaceuticals 650,000 shares (about $21.81M)Keros Therapeutics 2,000,000 shares (about $20.38M)89bio 2,500,000 shares (about $18.18M) Largest Sales this Quarter BioNTech 100,000 shares (about $9.11M)Ocular Therapeutix 1,200,000 shares (about $8.80M)Soleno Therapeutics 100,000 shares (about $7.15M)Trevi Therapeutics 825,285 shares (about $5.19M)Structure Therapeutics 275,000 shares (about $4.76M) Sector Allocation Over TimeMap of 500 Largest Holdings ofLogos Global Management Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorIDYAIDEAYA Biosciences$57,330,000$8,190,000 ▲16.7%3,500,00010.2%MedicalRVMDRevolution Medicines$56,576,000$5,304,000 ▲10.3%1,600,00010.1%MedicalAKROAkero Therapeutics$48,576,000$16,192,000 ▲50.0%1,200,0008.6%MedicalJANXJanux Therapeutics$44,550,000$10,800,000 ▲32.0%1,650,0007.9%MedicalNUVLNuvalent$35,460,000$35,460,000 ▲New Holding500,0006.3%MedicalTEVATeva Pharmaceutical Industries$26,129,000$26,129,000 ▲New Holding1,700,0004.6%MedicalXENEXenon Pharmaceuticals$21,807,500$21,807,500 ▲New Holding650,0003.9%MedicalKROSKeros Therapeutics$20,380,000$20,380,000 ▲New Holding2,000,0003.6%MedicalIRONDisc Medicine$19,575,137$9,647,137 ▲97.2%394,3423.5%MedicalBNTXBioNTech$18,212,000$9,106,000 ▼-33.3%200,0003.2%MedicalETNB89bio$18,175,000$18,175,000 ▲New Holding2,500,0003.2%MedicalSLNOSoleno Therapeutics$17,862,500$7,145,000 ▼-28.6%250,0003.2%MedicalERASErasca$17,810,000$685,000 ▲4.0%13,000,0003.2%MedicalOCULOcular Therapeutix$16,859,000$8,796,000 ▼-34.3%2,300,0003.0%MedicalDSGNDesign Therapeutics$16,280,0400.0%4,217,6272.9%MedicalMLTXMoonLake Immunotherapeutics$13,674,500$13,674,500 ▲New Holding350,0002.4%MedicalGERNGeron$12,720,000$9,540,000 ▲300.0%8,000,0002.3%MedicalOLMAOlema Pharmaceuticals$12,065,3700.0%3,208,8752.1%MedicalCRNXCrinetics Pharmaceuticals$11,739,000$11,739,000 ▲New Holding350,0002.1%MedicalRNAAvidity Biosciences$10,332,000$10,332,000 ▲New Holding350,0001.8%MedicalMAZE THERAPEUTICS INC$10,315,423$10,315,423 ▲New Holding936,9141.8%COMANNXAnnexon$7,720,000$2,798,500 ▲56.9%4,000,0001.4%MedicalGPCRStructure Therapeutics$7,356,750$4,760,250 ▼-39.3%425,0001.3%MedicalCMPSCOMPASS Pathways$5,720,000$5,720,000 ▲New Holding2,000,0001.0%MedicalDYNE THERAPEUTICS INC$5,230,000$523,000 ▲11.1%500,0000.9%COMELVNEnliven Therapeutics$4,723,200$1,968,000 ▲71.4%240,0000.8%MedicalIMVTImmunovant$4,699,750$427,250 ▼-8.3%275,0000.8%MedicalAVTEAerovate Therapeutics$3,514,0000.0%1,400,0000.6%MedicalACRSAclaris Therapeutics$3,400,0000.0%2,222,2220.6%MedicalUNCYUnicycive Therapeutics$2,919,8750.0%5,078,9270.5%MedicalTRVITrevi Therapeutics$2,671,457$5,191,042 ▼-66.0%424,7150.5%MedicalATXSAstria Therapeutics$2,670,0000.0%500,0000.5%MedicalRAPPORT THERAPEUTICS INC$2,095,3670.0%208,9100.4%COMGLYCGlycoMimetics$1,134,0000.0%5,400,0000.2%MedicalSEPTERNA INC$777,0300.0%134,2020.1%COMALLKAllakos$660,0400.0%2,900,0000.1%MedicalARTIVA BIOTHERAPEUTICS INC$435,2670.0%145,0890.1%COMSLDBSolid Biosciences$370,000$370,000 ▲New Holding100,0000.1%MedicalNUVATION BIO INC$15,9200.0%66,6660.0%*W EXP 02/10/202CYTKCytokinetics$0$42,336,000 ▼-100.0%00.0%MedicalVERAVera Therapeutics$0$37,003,750 ▼-100.0%00.0%MedicalMRUSMerus$0$31,537,500 ▼-100.0%00.0%MedicalINSMInsmed$0$31,068,000 ▼-100.0%00.0%MedicalNBIXNeurocrine Biosciences$0$27,300,000 ▼-100.0%00.0%MedicalPCVXVaxcyte$0$24,558,000 ▼-100.0%00.0%MedicalJAZZJazz Pharmaceuticals$0$21,551,250 ▼-100.0%00.0%MedicalBPMCBlueprint Medicines$0$17,444,000 ▼-100.0%00.0%MedicalTVTXTravere Therapeutics$0$17,420,000 ▼-100.0%00.0%MedicalAPLSApellis Pharmaceuticals$0$15,955,000 ▼-100.0%00.0%MedicalALKSAlkermes$0$14,380,000 ▼-100.0%00.0%MedicalAPOGEE THERAPEUTICS INC$0$13,590,000 ▼-100.0%00.0%COMARVNArvinas$0$13,419,000 ▼-100.0%00.0%MedicalSPYRE THERAPEUTICS INC$0$11,640,000 ▼-100.0%00.0%COM NEWEWTXEdgewise Therapeutics$0$10,680,000 ▼-100.0%00.0%MedicalPLRXPliant Therapeutics$0$9,877,500 ▼-100.0%00.0%MedicalBRIGHT MINDS BIOSCIENCES INC$0$8,824,900 ▼-100.0%00.0%COM NEWYMABY-mAbs Therapeutics$0$7,830,000 ▼-100.0%00.0%MedicalLIFEaTyr Pharma$0$3,620,000 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
